Inosine-5'-triphosphate trisodium salt

Catalog No. :
ACQXPJ164
CAS No. :
35908-31-7
Molecular Formula :
C10H12N4Na3O14P3
Molecular Weight :
574.11

IUPAC Name:sodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl hydrogen triphosphate

Inosine-5'-triphosphate trisodium salt structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$110.00Login to see priceIn stockInquiry
5g98%$406.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameInosine-5'-triphosphate trisodium salt
IUPAC Namesodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl hydrogen triphosphate
MDL No.MFCD00084678
Molecular FormulaC10H12N4Na3O14P3
Molecular Weight574.11
SMILESO=P([O-])(OP([O-])(OP(OC[C@H]1O[C@@H](N2C=NC3=C(O)N=CN=C23)[C@H](O)[C@@H]1O)([O-])=O)=O)O.[Na+].[Na+].[Na+]
InChI KeyQRGLCGLOQVQVCS-MSQVLRTGSA-K
SynonymITP | MFCD00084678 | Inosine-5'-triphosphate trisodium salt | ITP | AC-8223 | Inosine 5'-triphosphate trisodium salt | Inosine-5'-triphosphatetrisodiumsalt | AKOS016009828 | trisodium;[[[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]metho
CAS No.35908-31-7
PubChem CID135742691

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACQXPJ164 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQXPJ164 route product structure diagram
    ACQXPJ16435908-31-7 In Stock
Inquiry

2. ACQXPJ164 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQXPJ164 route product structure diagram
    ACQXPJ16435908-31-7 In Stock
Inquiry

Comments (0)